Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

intervet international b.v. - dueparamyxovirus-1( ppmv-1), stamme p201 (inaktiveret) - injektionsvæske, emulsion - fjerkræ

Den Europæiske Union - dansk - EMA (European Medicines Agency)

intervet international b.v. - celle-associerede live rekombinant tyrkiet herpesvirus (stamme hvp360), der udtrykker den fusion protein af nd virus og vp2 protein af ibd virus - aviær herpes virus (marek ' s disease) + aviær infectious bursal disease (gumboro disease) + newcastle disease/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

genera inc. - newcastle disease virus (ndv), stamme hitchner b1 (levende, svækket) - lyofilisat til okulonasal suspension/anvendelse i drikkevand - fjerkræ

Den Europæiske Union - dansk - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

leadiant gmbh - chenodeoxycholic syre - xanthomatosis, cerebrotendinous; metabolism, inborn errors - galde og lever terapi - chenodeoxycholic syre er indiceret til behandling af medfødte fejl af primære galdesyre syntese på grund af sterol 27 hydroxylase-mangel (præsentere som cerebrotendinous xanthomatosis (ctx)) hos spædbørn, børn og unge i alderen 1 måned til 18 år og voksne.